AccessMyLibrary : Search Information that Libraries Trust AccessMyLibrary | News, Research, and Information that Libraries Trust

AccessMyLibrary    Browse    A    Asia Africa Intelligence Wire    MAR-05    ABILIFY Now Applicable to Maintenance Treatment of Bipolar Disorder: FDA Approves New Indication.

ABILIFY Now Applicable to Maintenance Treatment of Bipolar Disorder: FDA Approves New Indication.

Publication: Asia Africa Intelligence Wire

Publication Date: 10-MAR-05
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.

Bookmark this article

Print this article

Link to this article

Email this article

Digg It!

Add to del.icio.us

RSS

COPYRIGHT 2005 Financial Times Ltd.

(From Japan Corporate News Network)

Byline: Dale Hug-Staff Writer, newsroom@japancorp.net

Bristrol-Myers Squibb (BMS) and Otsuka Pharmaceutical have jointly announced that the US Food and Drug Administration (FDA) approved an additional indication for ABILIFY (aripiprazole) Tablets and Oral Solution, atypical antipsychotics, as of March 1.

With this approval, ABILIFY is...

Read the full article for free courtesy of your local library.


More Articles from Asia Africa Intelligence Wire
Azeri opposition party elects new chairman.
March 13, 2005
Zimbabwe: Residents of capital reject Mugabe's plea not to vote for op...
March 13, 2005
Russian paper predicts modern planes for Kyrgyz air base.
March 13, 2005
Ethiopia to remain among highly corrupt states - global anti-graft bod...
March 13, 2005
Israel's Peres meets Afghan president, Arab leaders on fringes of Madr...
March 13, 2005

What's on AccessMyLibrary?

31,352,044 articles
in the following categories:

Arts, Business, Consumer News, Culture & Society, Education, Government, Personal Interest, Health, News, Science & Technology


© 2008 Gale, a part of Cengage Learning  | All Rights Reserved | About this Service | About The Gale Group, a part of Cengage Learning
                                            Privacy Policy | Site Map | Content Licensing | Contact Us | Link to us
      Other Gale sites: Books & Authors | Goliath | MovieRetriever.com | WiseTo Social Issues